P11 expression and PET in bipolar disorders

Journal of Psychiatric Research

Volumn 45, Issue 11, 2011, Pages 1426-1431

  Zhang, Lei ^a   Li, Cheng Ta ^b,c   Su, Tung Ping ^b,c   Hu, Xian Zhang ^a   Lanius, Ruth A ^d   Webster, Maree J ^e   Chung, Ming Yi ^b   Chen, Ying Sheue ^b   Bai, Ya Mei ^b   Barker, Jeffery L ^f   Barrett, James E ^g   Li, Xiao Xia ^a   Li, He ^a   Benedek, David M ^a   Ursano, Robert ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e Stanley Medical Research Institute   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Amygdala; Biomarker; Bipolar disorder I; Bipolar disorder II; P11; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; MESSENGER RNA; P11 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DISORDER; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPERMETABOLISM; INSULA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANNEXIN A2; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 80053948906     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.06.006     Document Type: Article

References (22)

1. Anisman H., Du L., Palkovits M., Faludi G., Kovacs G.G., Szontagh-Kishazi P., et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. Journal Psychiatry Neuroscience 2008, 33:131-141.
2. Brooks J.O., Wang P.W., Bonner J.C., Rosen A.C., Hoblyn J.C., Hill S.J., Ketter T.A. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Journal of Psychiatric Research 2009, 43:181-188.
3. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. Journal of Medical Genetics 2005, 42:193-204.
4. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., Raichle M.E. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacology Biochemistry and Behaviour 2002, 71:431-447.
5. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums 2008, 13:663-681.
6. Egeland M., Warner-Schmidt J., Greengard P., Svenningsson P. Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biological Psychiatry 2010, 67:1048-1056.
7. Friston K.J. Testing for anatomically specified regional effects. Human Brain Mapping 1997, 5:133-136.
8. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., Frackowiak R.S. The relationship between global and local changes in PET scans. Journal of Cerebral Blood Flow & Metabolism 1990, 10:458-466.
9. Gerke V., Weber K. The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S-100 protein of glial cells. EMBO Journal 1985, 4:2917-2920.
10. Gispert J.D., Pascau J., Reig S., Martinez-Lazaro R., Molina V., Garcia-Barreno P., Desco M. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage 2003, 19:601-612.
11. Hirschfeld R.M., Calabrese J.R., Frye M.A., Lavori P.W., Sachs G., Thase M.E., Wagner K.D. Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacology Bulletin 2007, 40:7-14.
12. Hosokawa T., Momose T., Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:243-250.
13. Manev H., Manev R. Nomen est Omen: do antidepressants increase p11 or S100A10?. Journal of Biomedical Discovery and Collaboration 2006, 1:5.
14. Michalak E.E., Murray G., Young A.H., Lam R.W. Burden of bipolar depression: impact of disorder and medications on quality of life. CNS Drugs 2008, 22:389-406.
15. Salvadore G., Drevets W.C., Henter I.D., Zarate C.A., Manji H.K. Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Intervention in Psychiatry 2008, 2:122-135.
16. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry 2000, 57:925-935.
17. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., et al. Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 2001, 50:271-280.
18. Svenningsson P., Chergui K., Rachleff I., Flajolet M., Zhang X., El Yacoubi M., et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006, 311:77-80.
19. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatrica Scandinavica 2000, 101:11-20.
20. Willis M.W., Ketter T.A., Kimbrell T.A., George M.S., Herscovitch P., Danielson A.L., et al. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Research 2002, 114:23-37.
21. Zhang L., Li H., Su T.P., Barker J.L., Maric D., Fullerton C.S., et al. p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter. Neuroscience 2008, 153:1126-1134.
22. Zimmerman M., Posternak M.A., Chelminski I. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. Journal of Psychiatric Research 2004, 38:577-582.